DarioHealth Revenue Rises 6.1% as Third-Quarter 2026 Loss Narrows

DarioHealth Corp. increased third-quarter 2026 revenue 6.1% year over year as its net loss narrowed, while operating expenses declined and cash totaled $31.2 million at quarter-end.

Revenue was $5.311 million for the three months ended Sept. 30, compared with $5.007 million in the year-earlier quarter. Net loss narrowed to $8.849 million from $10.466 million. Basic and diluted loss per share was $0.73.

Operating expenses declined 10% to $11.2 million. Operating loss was $8 million, down from $9.5 million a year earlier. Cash, cash equivalents and short-term deposits totaled $31.2 million as of Sept. 30.

“We grew revenue 6% year-over-year while reducing our operating expenses by 10% and our operating loss by 15%. Our B2B2C gross margin has remained strong, and we are focused on scaling that model,” Chief Financial Officer Chen Franco-Yehuda said.